Miricor Enterprises Holdings Limited (1827.HK)

HKD 1.14

(0.0%)

EBITDA Summary of Miricor Enterprises Holdings Limited

  • Miricor Enterprises Holdings Limited's latest annual EBITDA in 2023 was 86.61 Million HKD , up 248.94% from previous year.
  • Miricor Enterprises Holdings Limited's latest quarterly EBITDA in 2023 FY was N/A , up 248.94% from previous quarter.
  • Miricor Enterprises Holdings Limited reported an annual EBITDA of 70.34 Million HKD in 2022, down -74.22% from previous year.
  • Miricor Enterprises Holdings Limited reported an annual EBITDA of 94.01 Million HKD in 2021, up 445.84% from previous year.
  • Miricor Enterprises Holdings Limited reported a quarterly EBITDA of 14.29 Million HKD for 2023 Q4, down 0.0% from previous quarter.
  • Miricor Enterprises Holdings Limited reported a quarterly EBITDA of N/A for 2023 FY, up 248.94% from previous quarter.

Annual EBITDA Chart of Miricor Enterprises Holdings Limited (2023 - 2014)

Historical Annual EBITDA of Miricor Enterprises Holdings Limited (2023 - 2014)

Year EBITDA EBITDA Growth
2023 86.61 Million HKD 248.94%
2022 70.34 Million HKD -74.22%
2021 94.01 Million HKD 445.84%
2020 16.93 Million HKD -64.24%
2019 48.14 Million HKD 37.49%
2018 36.8 Million HKD -5.33%
2017 37.05 Million HKD -11.74%
2016 41.93 Million HKD 14.82%
2015 36.52 Million HKD 23.98%
2014 29.45 Million HKD 0.0%

Peer EBITDA Comparison of Miricor Enterprises Holdings Limited

Name EBITDA EBITDA Difference
Anxian Yuan China Holdings Limited 106.4 Million HKD 18.593%
Water Oasis Group Limited 345.33 Million HKD 74.917%
Perfect Medical Health Management Limited 577.56 Million HKD 85.003%
Fameglow Holdings Limited 93.66 Million HKD 7.519%